•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 

A02447 Summary:

BILL NOA02447
 
SAME ASNo Same As
 
SPONSORAbinanti
 
COSPNSR
 
MLTSPNSR
 
Add S2113, Pub Health L
 
Relates to the labeling of vaccines containing genetically modified organisms.
Go to top

A02447 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          2447
 
                               2015-2016 Regular Sessions
 
                   IN ASSEMBLY
 
                                    January 16, 2015
                                       ___________
 
        Introduced by M. of A. ABINANTI -- read once and referred to the Commit-
          tee on Health
 
        AN  ACT  to  amend the public health law, in relation to the labeling of
          vaccines containing genetically modified organisms
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.  The  public health law is amended by adding a new section
     2  2113 to read as follows:
     3    § 2113. Genetically modified vaccines; required labeling  and  notice.
     4  1. As used in this section, the term:
     5    (a) "Genetically modified," "genetic modification," "genetically engi-
     6  neered,"  or  "genetic  engineering"  as  applied  to any vaccine, means
     7  produced from or with an organism or  organisms  with  genetics  altered
     8  materially through the application of:
     9    (i)  in  vitro  nucleic  acid techniques, including but not limited to
    10  recombinant  deoxyribonucleic  acid  (DNA)  techniques  and  the  direct
    11  injection of nucleic acid into cells or organelles, or
    12    (ii) fusion of cells beyond the taxonomic family that overcome natural
    13  physiological  reproductive  or  recombinant  barriers  and that are not
    14  techniques used in traditional breeding and selection.
    15    (b) "Manufacturer" means a person or business that  makes,  processes,
    16  combines or packages a vaccine.
    17    2. Any vaccine offered in New York is misbranded if it contains genet-
    18  ically  modified organisms partially or in its entirety and that fact is
    19  not disclosed.
    20    3. In the case of a genetically modified vaccine,  the  words  "genet-
    21  ically  modified"  shall  be placed on the container used for packaging,
    22  holding and/or transport in  a  clear  and  conspicuous  manner  by  the
    23  manufacturer.
    24    4.  This  section shall not be construed to require either the listing
    25  or identification of any ingredient or ingredients that were genetically
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD04829-01-5

        A. 2447                             2
 
     1  modified, nor that the term "genetically modified" be placed immediately
     2  preceding any common name or primary product descriptor of a vaccine.
     3    5.  In the case of a genetically modified vaccine, the doctor or other
     4  individual administering the vaccine shall notify the recipient  of  the
     5  genetically modified vaccine prior to administering said vaccine.
     6    §  2.  This  act shall take effect on the ninetieth day after it shall
     7  have become a law.
Go to top